CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Aventis Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 10, 2021Novel Antitumoral Use Of Cabazitaxel13
Dec 18, 2019Cabazitaxel And Its Use For Treating Cancer9
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And Cisplatin1

Top competitors of Aventis Pharma

List of top competitors of Aventis Pharma based on patent oppositions.